GEM 21S Equimatrix Heli Products Mucograft References Download Center Video Education Center Lecture Materials
Professionals Patients Contact Us About Us
PRODUCTS
NEWS
EVENTS
RESOURCES
CONTACT US
Contact Us Form
Request Rep Contact
PLACE AN ORDER
REQUEST PRODUCT INFORMATION
LOGIN SITE MAP

Contact Us

   

Corporate contact information  

Osteohealth

 

One Luitpold Drive

 

P.O. Box 9001

 

Shirley, NY 11967

 

Phone: (631) 924-4000

 

Fax: (631) 924-1731

 

Website: www.osteohealth.com

 

Service and Support

Our customer service representatives are available by phone Monday through Friday from 8:30 am - 7:00 pm EST to support all of your needs including technical assistance and the provision of product information.

 

Phone: (800) 874-2334

Email: info@osteohealth.com

 

 

Order online anytime

www.luitpoldonline.com/osteohealth

 

New Business Development

 

 

 

If you would like to learn more about becoming an Osteohealth distributor or partner, please contact us via email at businessdevelopment@osteohealth.com

Clinical Research & Development

 

 

If you would like to inquire about or participate in the research and development of Osteohealth products, please contact us via email at clinicalresearch@osteohealth.com

 

 

To Report Medical Device Report (MDRs):

(Osteohealth Company)

 

 

 

To Report a Product Quality

Complaint to any products

from the Osteohealth

Company

Fax: 610-650-0170

Phone: 800-734-9236

Email: pv@osteohealth.com

Contact Us Form 

 

 

Please call toll-free 1-888-354-4859

Or Email: pqc@luitpold.com

SEARCH:
Osteohealth Company   |   Contact Us   |   © 2014 Luitpold Pharmaceuticals, Inc. Company   |   Privacy Policy   |   Terms of Use
DAIICHI SANKYO NAMES NEW PRESIDENT OF US SUBSIDIARY LUITPOLD PHARMACEUTICALS, INC.

June 29, 2016 – Effective today, Ken Keller has been newly appointed as President and CEO of Luitpold Pharmaceuticals, in addition to his current position as President, Daiichi Sankyo Administrative and Commercial, Daiichi Sankyo, Inc.

With more than 25 years of experience in the pharmaceutical industry in commercial leadership and joint venture leadership, Mr. Keller will now oversee both the Daiichi Sankyo, Inc. Commercial organization and Luitpold Pharmaceuticals, Inc.

Mr. Keller joined Daiichi Sankyo, Inc. in 2014 and has also served on the Luitpold Board of Directors since 2015. He has successfully led the Daiichi Sankyo, Inc. US commercial organization as it begins its transformation to a specialty focused company.

“While Luitpold and Daiichi Sankyo US businesses serve different customers and markets, they each bring to the table important strengths and focus that are essential to the continued success and growth of the Daiichi Sankyo Group,” said Ken Keller. “I look forward to working with the Luitpold team and driving even further success in the future.”

Luitpold Pharmaceuticals, Inc. is a Daiichi Sankyo Group Company headquartered in Shirley, NY, and manufactures more than 80 pharmaceutical products.